Line-Up Announced for iSOFT-Sponsored ePMA Excellence Forums

iSOFTSteve Freeborn, a renowned pharmacist and contributor to the landmark report on medication errors, 'A Spoonful of Sugar - Medicines management in NHS hospitals', will be among the speakers at iSOFT-sponsored e-prescribing conferences at Wembley on 20 October and Old Trafford on 10 November.

Freeborn's keynote address, "There and back again - a pharmacist's tale", will describe how pharmacy management in the NHS has witnessed many changes over the years, yet advanced relatively little.

In a recent article, Freeborn said traditionally the NHS lacked the drive to make e-prescribing a reality but the current cost cutting is a game-changer, as it risks patient safety.

"The line-up of distinguished speakers from academia and the NHS promises a lively debate and useful exchange of ideas," said Adrian Stevens, managing director of iSOFT's UK and Ireland business, who is hosting the events.

Both ePMA Excellence Forums are free and open to anyone wanting to learn more about the realities of implementing an e-prescribing and medicines administration (ePMA) system. To reserve a place, click here.

Other speakers and sessions include:

  • Dr Rachel Howard, University of Reading; “People and computers: error producing or defensive?”
  • Prof Tim Dornan, University of Maastricht; “Education and the impact on prescribing behaviours.”

There are also sessions offering some practical advice on implementing ePMA systems in the NHS:

  • Helen Bennett, Stockport NHS Foundation Trust; “Establishing baseline and performance measures.”
  • Alex Jennings, University Hospital Aintree; “ePMA risks and benefits.”
  • Steve Wardell and Bala Sridhar, The Christie Hospital NHS Foundation Trust; “Implementing a complex ePMA solution.”

Related news articles:

About iSOFT, a CSC company
Headquartered in Banbury, UK, iSOFT is one of the world's largest healthcare IT companies serving 13,000 healthcare providers in over 40 countries across five continents. Its software product portfolio is one of the most extensive available, covering every aspect of healthcare delivery and planning. These include interoperable e-health solutions that build on existing systems to maximise current investments.

iSOFT's business is driven by the collective talent, experience and commitment of over 3,000 specialists in 19 countries. Through a global network of subsidiaries and extensive partner network, iSOFT also has substantial experience of national healthcare sectors and expert knowledge of local market needs.

iSOFT is a CSC company.

Most Popular Now

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...